Article
Public (all visitors)
Big pharma’s patent cliff is fast approaching | The Economist
The Economist
2023
A flurry of deals suggests that drug firms favour buying their way out of trouble. Will face competition from cheaper copycats once key patents expire in 2028 in America and Europe two years later | Business
Browse more
View all ArticlesContribute to FoundryBase
Found something worth adding?
Sign in to suggest resources and start building your own collection.